Shi Shuangping
Director, Preclinical Development Immunoassay & Ne
R&D
The Johns Hopkins University
Austria
Biography
When Shuangping Shi, director, Biologics & Vaccines Bioanalytics, Biologics and Vaccines, MSD Research Laboratories, joined Schering-Plough in 2006 from The Rockefeller University, she developed a proprietary protein expression system that has been at the forefront of cancer immunotherapy in the U.S. In her current role, Shuangping looks at efficacy and safety measures to determine whether cancer drugs are binding to the target and activating the immune response. "The most exciting part of my job is when I see if a drug is working," she says. "Little by little, we hope that our work will change the course of public health."
Research Interest
biological engineering, pharmaceutical biotechnology, Organic Chemistry, Pharmaceutical Chemistry
